These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15635283)
1. [High throughput screening of pharmacokinetics and metabolism in drug discovery (I)--establishment of assessment system for absorption to compounds with a wide diversity of physical properties]. Komura H; Kawahara I; Shigemoto Y; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH Yakugaku Zasshi; 2005 Jan; 125(1):121-30. PubMed ID: 15635283 [TBL] [Abstract][Full Text] [Related]
2. [High throughput screening of pharmacokinetics and metabolism in drug discovery (II)--investigation on in vitro and in vivo correlation in drug metabolism screening]. Komura H; Matsuda K; Shigemoto Y; Kawahara I; Ano R; Murayama Y; Moriwaki T; Yoshida NH Yakugaku Zasshi; 2005 Jan; 125(1):131-9. PubMed ID: 15635284 [TBL] [Abstract][Full Text] [Related]
3. [High throughput screening of pharmacokinetics and metabolism in drug discovery (III)--investigation on in- silico model for membrane permeability and CYP1A2 inhibition]. Komura H; Shigemoto Y; Kawahara I; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH Yakugaku Zasshi; 2005 Jan; 125(1):141-7. PubMed ID: 15635285 [TBL] [Abstract][Full Text] [Related]
4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
5. Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery. Zhou L; Yang L; Tilton S; Wang J J Pharm Sci; 2007 Nov; 96(11):3052-71. PubMed ID: 17722003 [TBL] [Abstract][Full Text] [Related]
6. A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC-UV-CLND quantification. Lin B; Pease JH J Pharm Biomed Anal; 2016 Apr; 122():126-40. PubMed ID: 26855285 [TBL] [Abstract][Full Text] [Related]
7. Prediction of human pharmacokinetics--gastrointestinal absorption. Fagerholm U J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184 [TBL] [Abstract][Full Text] [Related]
8. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. Roberts SA Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader. Chen TM; Shen H; Zhu C Comb Chem High Throughput Screen; 2002 Nov; 5(7):575-81. PubMed ID: 12470271 [TBL] [Abstract][Full Text] [Related]
10. Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species. Wuelfing WP; Daublain P; Kesisoglou F; Templeton A; McGregor C Mol Pharm; 2015 Apr; 12(4):1031-9. PubMed ID: 25671350 [TBL] [Abstract][Full Text] [Related]
11. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions. Muenster U; Pelzetter C; Backensfeld T; Ohm A; Kuhlmann T; Mueller H; Lustig K; Keldenich J; Greschat S; Göller AH; Gnoth MJ Eur J Pharm Biopharm; 2011 Aug; 78(3):522-30. PubMed ID: 21315152 [TBL] [Abstract][Full Text] [Related]
13. [Development of solubility screening methods in drug discovery]. Sugaya Y; Yoshiba T; Kajima T; Ishihama Y Yakugaku Zasshi; 2002 Mar; 122(3):237-46. PubMed ID: 11905048 [TBL] [Abstract][Full Text] [Related]
14. High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media. Bard B; Martel S; Carrupt PA Eur J Pharm Sci; 2008 Mar; 33(3):230-40. PubMed ID: 18207706 [TBL] [Abstract][Full Text] [Related]
15. Addition of Optimized Bovine Serum Albumin Level in a High-Throughput Caco-2 Assay Enabled Accurate Permeability Assessment for Lipophilic Compounds. Cai X; Madari S; Walker A; Paiva A; Li Y; Herbst J; Shou W; Weller H SLAS Discov; 2019 Aug; 24(7):738-744. PubMed ID: 31076010 [TBL] [Abstract][Full Text] [Related]
16. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151 [TBL] [Abstract][Full Text] [Related]
17. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Taub ME; Kristensen L; Frokjaer S Eur J Pharm Sci; 2002 May; 15(4):331-40. PubMed ID: 11988394 [TBL] [Abstract][Full Text] [Related]
18. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties]. Deák K Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088 [TBL] [Abstract][Full Text] [Related]
19. High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery. Wan H; Holmén AG Comb Chem High Throughput Screen; 2009 Mar; 12(3):315-29. PubMed ID: 19275537 [TBL] [Abstract][Full Text] [Related]
20. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions. Balakin KV; Savchuk NP; Tetko IV Curr Med Chem; 2006; 13(2):223-41. PubMed ID: 16472214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]